Peroxisome proliferator-activated receptor gamma (PPARγ) and its ligands:: A review

被引:212
|
作者
Houseknecht, KL [1 ]
Cole, BM [1 ]
Steele, PJ [1 ]
机构
[1] Pfizer Global Res & Dev, Groton, CT 06340 USA
关键词
D O I
10.1016/S0739-7240(01)00117-5
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Peroxisome proliferator-activated receptor gamma (PPARgamma) is a member of a class of nuclear hormone receptors intimately involved in the regulation of expression of myriad genes that regulate energy metabolism, cell differentiation, apoptosis and inflammation. Although originally discovered as a pivotal regulator of adipocyte differentiation, the roles that this transcription factor play in physiology and pathophysiology continue to grow as researchers discover its influence in the function of many cell types. This review highlights the roles that PPARgamma play in the regulation of gene expression associated with normal cell physiology as well as the pathophysiology of multiple diseases including obesity, diabetes and cancer. Additionally, naturally occurring and pharmaceutical ligands for the receptor as well as the potential role of PPARgamma as the receptor responsible for fatty acid-induced effects on gene expression will be described. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1 / 23
页数:23
相关论文
共 50 条
  • [1] Peroxisome proliferator-activated receptor gamma (PPARγ) ligands are potent inhibitors of angiogenesis
    Xin, X
    Yang, S
    Kowalski, J
    Gerritsen, ME
    [J]. FASEB JOURNAL, 1999, 13 (04): : A39 - A39
  • [2] Ligands and Regulatory Modes of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Avians
    Navidshad, B.
    Royan, M.
    [J]. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2015, 25 (04): : 287 - 292
  • [3] Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma
    Sauer, Sascha
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (10) : 688 - 704
  • [4] Prostaglandins are weak ligands of the peroxisome proliferator-activated receptor γ (PPARγ).
    Ferry, G
    Bruneau, V
    Beauverger, P
    Goussard, M
    Rodriguez, M
    Levens, N
    Galizzi, JP
    Boutin, JA
    [J]. FASEB JOURNAL, 2000, 14 (08): : A1441 - A1441
  • [5] Peroxisome proliferator-activated receptor gamma (PPARγ) activation and its consequences in humans
    Bar-Tana, J
    [J]. TOXICOLOGY LETTERS, 2001, 120 (1-3) : 9 - 19
  • [6] Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands
    Fidaleo, Marco
    Fanelli, Francesca
    Ceru, Maria Paola
    Moreno, Sandra
    [J]. CURRENT MEDICINAL CHEMISTRY, 2014, 21 (24) : 2803 - 2821
  • [7] Peroxisome proliferator-activated receptor-gamma ligands: Thiazolidinediones
    Zingarelli, B
    [J]. SHOCK, 2004, 21 : 126 - 126
  • [8] The Need for Physiologically Relevant Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ) Ligands
    Subramani, Parasuraman Aiya
    Reddy, Madhava C.
    Narala, Venkata R.
    [J]. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2013, 13 (02) : 175 - 183
  • [9] Targeting Glioblastoma Stem Cells (GSCs) with Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Ligands
    Im, Chang-Nim
    [J]. IUBMB LIFE, 2016, 68 (03) : 173 - 177
  • [10] Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR-γ): a review
    Wang, Limei
    Waltenberger, Birgit
    Pferschy-Wenzig, Eva-Maria
    Blunder, Martina
    Liu, Xin
    Malainer, Clemens
    Blazevic, Tina
    Schwaiger, Stefan
    Rollinger, Judith M.
    Heiss, Elke H.
    Schuster, Daniela
    Kopp, Brigitte
    Bauer, Rudolf
    Stuppner, Hermann
    Dirsch, Verena M.
    Atanasov, Atanas G.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2014, 92 (01) : 73 - 89